Charanjit Kaur
Nurse Practitioner · Manteca, CANPI 1285243360
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,004 of the $3,236 with a category attached, or 61.9%. Inspire Medical Systems, Inc. accounts for 77.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $2,451 and has fallen 84.8% since, to $372 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $87.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Jazz Pharmaceuticals Inc.$358
- Axsome Therapeutics, Inc.$129
- Idorsia Pharmaceuticals US Inc$83
- Harmony Biosciences LLC$55
- Avadel CNS Pharmaceuticals, LLC$43
- plus $48 from 2 others
What the payments were for
- Travel & lodging$2,00462%
- Food & beverage$1,07233%
- Education$1605%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 17 | $2,520 |
| Jazz Pharmaceuticals Inc. | 5 | $358 |
| Axsome Therapeutics, Inc. | 6 | $129 |
| Idorsia Pharmaceuticals US Inc | 2 | $83 |
| Harmony Biosciences LLC | 3 | $55 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $43 |
| Lilly USA, LLC | 1 | $27 |
| AstraZeneca | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,236 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 21 | $6,793 |
| Fluticasone Propionate | 11 | $254 |
| Sertraline Hcl | 23 | $129 |
| Gabapentin | 17 | $74 |
| Trazodone Hcl | 18 | $45 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Manteca
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.